BioSig Technologies Inc. (BSGM)
| Bid | 0.5 |
| Market Cap | 12.21M |
| Revenue (ttm) | 56.22K |
| Net Income (ttm) | -22.03M |
| EPS (ttm) | -1.34 |
| PE Ratio (ttm) | -0.4 |
| Forward PE | -1.26 |
| Analyst | Strong Buy |
| Ask | 0.53 |
| Volume | 387,790 |
| Avg. Volume (20D) | 284,844 |
| Open | 0.51 |
| Previous Close | 0.49 |
| Day's Range | 0.50 - 0.55 |
| 52-Week Range | 0.20 - 2.98 |
| Beta | 0.43 |
About BSGM
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses ...
Analyst Forecast
According to 1 analyst ratings, the average rating for BSGM stock is "Strong Buy." The 12-month stock price forecast is $2.75, which is an increase of 418.87% from the latest price.
Stock Forecasts
2 years ago · proactiveinvestors.com
BioSig Technologies says Kansas City Heart Institute signs purchase agreement for its PURE EP SystemBioSig Technologies Inc has announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, USA, has signed a purchase agreement to acquire its PURE EP System. Foll...
2 years ago · proactiveinvestors.com
BioSig Technologies gets repeat 'Outperform' tag, $4 price target from Noble CapitalBioSig Technologies Inc has earned a reiterated ‘Outperform' rating and $4 price target from analysts at Noble Capital days after pricing a public offering that generated proceeds of $2.9 million. Th...